New Alzheimer’s Drug Slows Disease By A Third

UNITED STATES – Experts say we could be entering the era of Alzheimer’s treatments, after the second drug in under a year has been shown to slow the disease.

It’s something they say had previously recently seemed “impossible”. The company Eli Lilly has reported its drug – Donanemab – slows the pace of Alzheimer’s by about a third.

However two volunteers, and possibly a third, died as a result of dangerous swelling in the brain.

Donanemab works in the same way as Lecanemab, which created headlines around the world when it was the proven to slow the disease.